Oncology Companion Diagnostic Market to Value USD 14.65 Billion by 2035, Registering 11.09% CAGR – SNS Insider
U.S. Market Valued at USD 2.17 Billion in 2025 While Europe Reaches USD 1.47 Billion as Biomarker-Based Cancer Testing Expands. Austin, United States, June 08, 2026 (GLOBE NEWSWIRE) — “The Oncology Companion Diagnostic Market was valued at USD 5.09 Billion …